Bicycle (BCYC) Q2 Revenue Falls 69%
Bicycle Therapeutics Plc (NASDAQ:BCYC) reported Q2 2025 GAAP revenue of $2.9 million, significantly below the $9.43 million analyst estimate, while ...
Friday, August 8, 2025
Tag: BCYC
News Summarized. Time Saved. Bite-sized news briefs for busy people. No fluff, just facts.